Immune checkpoint analysis showed that, except for HHLA2, which was significantly overexpressed in the low-risk group, the remaining 21 immune checkpoint genes (ICGs) were significantly upregulated in the high-risk population, indicating a more severe state of tumor immunosuppression. The gene discussed is HHLA2; the disease is neoplasm.